netFormulary
 Report : A-Z HCD items in Formulary 06/07/2020 00:55:46
[Back]
 
Section Status HCD Name
05.03.01 Formulary Cancer Drugs Fund Abacavir Ziagen®
05.03.01 Formulary Cancer Drugs Fund Abacavir and Lamivudine Kivexa®
05.03.01 Formulary Cancer Drugs Fund Abacavir and Lamivudine and Zidovudine Trizivir®
10.01.03 Formulary Cancer Drugs Fund Abatacept Orencia®
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga®
01.05.03 Formulary Cancer Drugs Fund Adalimumab 
10.01.03 Formulary Cancer Drugs Fund Adalimumab Humira®
13.05.03 Formulary Cancer Drugs Fund Adalimumab 
05.03.03.01 Formulary Cancer Drugs Fund Adefovir Dipivoxil Hepsera®
11.08.02 Formulary Cancer Drugs Fund Aflibercept 
09.08.01 Non Formulary Cancer Drugs Fund Agalsidase Alfa and Beta Fabrazyme®
09.08.01 Non Formulary Cancer Drugs Fund Agalsidase Alfa and Beta Replagal®
08.01.05 Formulary Cancer Drugs Fund Alectinib Alecensa®
08.02.03 Formulary Cancer Drugs Fund Alemtuzumab Lemtrada®
09.08.01 Non Formulary Cancer Drugs Fund Alglucosidase Alfa Myozyme®
02.14 Restricted Use Cancer Drugs Fund Alirocumab Praluent®
13.05.01 Formulary Cancer Drugs Fund Alitretinoin Toctino®
05.02 Formulary Cancer Drugs Fund Amphotericin Abelcet ® AmBisome ® Fungizone ®
10.01.03 Non Formulary Cancer Drugs Fund Anakinra Kineret®
05.02.04 Formulary Cancer Drugs Fund Anidulafungin Ecalta®
09.01.03 Non Formulary Cancer Drugs Fund Antithymocyte Immunoglobulin (Equine) 
10.01.03 Formulary Cancer Drugs Fund Apremilast  (Ortezla® )
13.05.03 Formulary Cancer Drugs Fund Apremilast Otezla®
08.01.05 Formulary Cancer Drugs Fund Arsenic Trioxide Trisenox®
05.03.01 Formulary Cancer Drugs Fund Atazanavir Reyataz®
08.02.04 Formulary Cancer Drugs Fund Atezolizumab  (Tecentriq®)
08.02.04 Formulary Cancer Drugs Fund Avelumab  (Bavencio®)
08.02.04 Formulary Cancer Drugs Fund Axicabtagene ciloleuce (Yescarta®)
08.01.05 Formulary Cancer Drugs Fund Axitinib Inlyta®
08.01.03 Formulary Cancer Drugs Fund Azacitidine Vidaza®
10.01.03 Formulary Cancer Drugs Fund Baricitinib  (Olumiant®)
08.02.02 Formulary Cancer Drugs Fund Basiliximab Simulect®
10.01 Formulary Cancer Drugs Fund Belimumab Benlysta®
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
03.05.02 Formulary Cancer Drugs Fund Beractant Survanta®
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Formulary Cancer Drugs Fund Bexarotene Targretin®
08.02 Formulary Cancer Drugs Fund Blinatumomab Blincyto®
05.03.03.02 Formulary Cancer Drugs Fund Boceprevir Victrelis®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
04.07.04.02 Formulary Cancer Drugs Fund Botulinum Toxin Type A botox®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
03.04.03 Non Formulary Cancer Drugs Fund C1 esterase inhibitor Cinryze®
03.04.03 Formulary Cancer Drugs Fund C1 Esterase Inhibitor Berinert®
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana®
08.01.05 Formulary Cancer Drugs Fund Carfilzomib Kyprolis®
09.08.01 Non Formulary Cancer Drugs Fund Carglumic Acid Carbaglu®
05.02.04 Formulary Cancer Drugs Fund Caspofungin Cancidas®
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia
10.01.03 Formulary Cancer Drugs Fund Certolizumab Pegol Cimzia®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.02.02 Formulary Cancer Drugs Fund Ciclosporin 
09.05.01.02 Non Formulary Cancer Drugs Fund Cinacalcet Mimpara®
08.01.03 Formulary Cancer Drugs Fund Cladribine Mavenclad®
08.01.03 Formulary Cancer Drugs Fund Cladribine 
08.01.03 Formulary Cancer Drugs Fund Clofarabine Evoltra®
05.03.01 Formulary Cancer Drugs Fund Cobicistat Tybost®
09.05.02.02 Non Formulary Cancer Drugs Fund Colestilan BindRen®
05.01.07 Formulary Cancer Drugs Fund Colistimethate for nebulisation Colobreathe®
05.01.07 Formulary Cancer Drugs Fund Colistimethate for nebulisation Promixin®
10.03.01 Formulary Cancer Drugs Fund Collagenase Xiapex®
03.04.03 Formulary Cancer Drugs Fund Conestat Alfa Ruconest®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar®
05.03.03.02 Restricted Use Cancer Drugs Fund Daclatasvir  Daklinza®
08.02.04 Formulary Cancer Drugs Fund Daratumumab  (Darzalex®)
09.01.03 Non Formulary Cancer Drugs Fund Darbepoetin Alfa Aranesp®
05.03.03.02 Formulary Cancer Drugs Fund Dasabuvir Exviera®
08.01.05 Restricted Use Cancer Drugs Fund Dasatinib Sprycel®
20 Non Formulary Cancer Drugs Fund DAUNORUBICIN saline pre-filled syringe 
09.01.03 Non Formulary Cancer Drugs Fund Deferasirox Exjade®
09.01.03 Non Formulary Cancer Drugs Fund Deferiprone Ferriprox®
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Capsules 400 mg 
20 Non Formulary Cancer Drugs Fund DEFIBROTIDE Injection 200 mg 
05.01.09 Non Formulary Cancer Drugs Fund Delamanid Deltyba®
09.01.03 Non Formulary Cancer Drugs Fund Desferrioxamine Mesilate 
05.03.01 Formulary Cancer Drugs Fund Didanosine Videx®
02.01.01 Non Formulary Cancer Drugs Fund Digoxin specific antibody fragments Digifab®
18 Non Formulary Cancer Drugs Fund Digoxin specific antibody fragments Digifab®
08.02.04 Formulary Cancer Drugs Fund Dimethyl fumarate Tecfidera®
08.02.04 Formulary Cancer Drugs Fund Dinutuximab  (Qarziba®)
08.01.05 Formulary Cancer Drugs Fund Docetaxel Taxotere®
05.03.01 Formulary Cancer Drugs Fund Dolutegravir tivicay ®
05.03.01 Formulary Cancer Drugs Fund Dolutegravir, abacavir & lamivudine Triumeq®
03.07 Formulary Cancer Drugs Fund Dornase Alfa 
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Caelyx®
08.02.04 Formulary Cancer Drugs Fund Durvalumab   (Imfinzi® )
09.01.03 Non Formulary Cancer Drugs Fund Eculizumab 
05.03.01 Formulary Cancer Drugs Fund Efavirenz Sustiva®
09.08.01 Non Formulary Cancer Drugs Fund Eliglustat Cerdelga®
09.01.04 Non Formulary Cancer Drugs Fund Eltrombopag Revolade®
05.03.01 Formulary Cancer Drugs Fund Emtricitabine Emtriva®
05.03.01 Formulary Cancer Drugs Fund Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg Eviplera®
05.03.03.01 Formulary Cancer Drugs Fund Entecavir Baraclude®
08.03.04.02 Formulary Cancer Drugs Fund Enzalutamide Xtandi®
09.01.03 Non Formulary Cancer Drugs Fund Epoetin alfa Eprex®
09.01.03 Non Formulary Cancer Drugs Fund Epoetin beta NeoRecormon®
20 Non Formulary Cancer Drugs Fund Eptotermin Alfa  Osigraft®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Erlotinib Tarceva®
08.01.05 Formulary Cancer Drugs Fund Erlotinib Tarceva®
10.01.03 Formulary Cancer Drugs Fund Etanercept Enbrel®
13.05.03 Formulary Cancer Drugs Fund Etanercept 
05.03.01 Formulary Cancer Drugs Fund Etravirine Intelence®
08.01.05 Formulary Cancer Drugs Fund Everolimus Votubia®
08.01.05 Restricted Use Cancer Drugs Fund Everolimus Afinitor®
02.14 Restricted Use Cancer Drugs Fund Evolocumab Repatha®
02.11 Restricted Use Cancer Drugs Fund Factor VIIa (Recombinant) Novo 7®
09.01.06 Non Formulary Cancer Drugs Fund Filgrastim Nivestim®
09.01.06 Non Formulary Cancer Drugs Fund Filgrastim Neupogen®
08.02.04 Formulary Cancer Drugs Fund Fingolimod 
11.04.01 Formulary Cancer Drugs Fund Fluocinolone intravitreal implant Iluvien®
18 Non Formulary Cancer Drugs Fund Fomepizole 
05.03.01 Formulary Cancer Drugs Fund Fosamprenavir Telzir®
05.03.02.02 Formulary Cancer Drugs Fund Ganciclovir Cymevene®
08.01.05 Formulary Cancer Drugs Fund Gefitinib Iressa®
08.02.04 Formulary Cancer Drugs Fund Glatiramer Acetate Copaxone®
05.03.03.02 Formulary Cancer Drugs Fund Glecaprevir and Pibrentasvir Maviret®
18 Non Formulary Cancer Drugs Fund Glucarpidase Carboxypeptidase
01.05.03 Formulary Cancer Drugs Fund Golimumab 
10.01.03 Formulary Cancer Drugs Fund Golimumab Simponi®
09.08.02 Non Formulary Cancer Drugs Fund Haem Arginate Normosang®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
03.04.03 Formulary Cancer Drugs Fund Icatibant Firazyr®
02.05.01 Formulary Cancer Drugs Fund Iloprost injection  
08.01.05 Formulary Cancer Drugs Fund Imatinib Gilvec®
09.08.01 Non Formulary Cancer Drugs Fund Imiglucerase Cerezyme®
08.02.04 Formulary Cancer Drugs Fund Immunocellular therapy containing tisagenlecleucel, autologous T cells genetically modified ex vivo using a lentiviral vector encoding an anti-CD19 chimeric antigen receptor (CAR) (Kymriah®)
01.05.03 Formulary Cancer Drugs Fund Infliximab 
10.01.03 Formulary Cancer Drugs Fund Infliximab Remicade®
13.05.03 Formulary Cancer Drugs Fund Infliximab 
08.01 Formulary Cancer Drugs Fund Inotuzumab ozogamicin Besponsa®
08.02.04 Formulary Cancer Drugs Fund Interferon Alfa 
08.02.04 Formulary Cancer Drugs Fund Interferon Alfa Roferon-A®
08.02.04 Formulary Cancer Drugs Fund Interferon Beta Rebif®
08.02.04 Formulary Cancer Drugs Fund Interferon Beta Betaferon®
08.02.04 Formulary Cancer Drugs Fund Interferon Beta Avonex®
08.02.04 Formulary Cancer Drugs Fund Interferon beta Extavia®
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy®
08.01.05 Formulary Cancer Drugs Fund Ixazomib Ninlaro®
05.03.01 Formulary Cancer Drugs Fund Lamivudine Epivir®
05.03.01 Formulary Cancer Drugs Fund Lamivudine Zeffix®
08.03.04.03 Formulary Cancer Drugs Fund Lanreotide 
09.05.02.02 Non Formulary Cancer Drugs Fund Lanthanum Fosrenol ®
09.08.01 Non Formulary Cancer Drugs Fund Laronidase Aldurazyme®
05.03.03.02 Formulary Cancer Drugs Fund Ledipasvir and Sofosbuvir Harvoni®
08.02.04 Formulary Cancer Drugs Fund Lenalidomide 
09.01.06 Non Formulary Cancer Drugs Fund Lenograstim Granocyte®
08.01.05 Formulary Cancer Drugs Fund Lenvatinib Lenvima® and Kisplyx®
09.08.01 Non Formulary Cancer Drugs Fund Levocarnitine Carnitor®
05.03.01 Formulary Cancer Drugs Fund Lopinavir and Ritonavir Kaletra®
03.07 Formulary Cancer Drugs Fund Mannitol inhalation Bronchitol ®
05.03.01 Formulary Cancer Drugs Fund Maraviroc Celsentri®
09.08.01 Non Formulary Cancer Drugs Fund Mercaptamine Cystagon®
09.08.01 Non Formulary Cancer Drugs Fund Mercaptamine (cysteamine) eye drops  
09.01.03 Non Formulary Cancer Drugs Fund Methoxy Polyethylene Glycol-Epoetin Beta Mircera®
08.01.05 Formulary Cancer Drugs Fund Midostaurin Rydapt®
09.08.01 Non Formulary Cancer Drugs Fund Miglustat Zavesca®
08.02.01 Formulary Cancer Drugs Fund Mycophenolate Mofetil 
08.02.04 Formulary Cancer Drugs Fund Natalizumab Tysabri®
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance®
05.03.01 Formulary Cancer Drugs Fund Nevirapine Viramune®
08.01.05 Formulary Cancer Drugs Fund Nilotinib Tasigna®
03.11 Formulary Cancer Drugs Fund Nintedanib Ofev®
08.01.05 Formulary Cancer Drugs Fund Nintedanib Vargatef ®
08.02.04 Formulary Cancer Drugs Fund Niraparib (Zejula®)
20 Non Formulary Cancer Drugs Fund Nitazoxanide 
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo®
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin for Intramuscular use 
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin for Intravenous use 
14.05.01 Non Formulary Cancer Drugs Fund Normal immunoglobulin for Subcutaneous use 
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro ®
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin Lar®
08.03.04.03 Formulary Cancer Drugs Fund Octreotide Sandostatin®
08.02.03 Formulary Cancer Drugs Fund Ofatumumab Arzerra®
08.02.04 Formulary Cancer Drugs Fund Olaparib Lynparza®
08.01.05 Formulary Cancer Drugs Fund Olaratumab Lartruvo®
03.04.02 Formulary Cancer Drugs Fund Omalizumab 
05.03.03.02 Formulary Cancer Drugs Fund Ombitasvir/ paritaprevir/ ritonavir Viekirax®
08.02.04 Formulary Cancer Drugs Fund Osimertinib Tagrisso
08.01.05 Formulary Cancer Drugs Fund Paclitaxel - Albumin Bound Formulation Abraxane®
05.03.05 Restricted Use Cancer Drugs Fund Palivizumab Synagis®
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix®
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak®
08.01.05 Formulary Cancer Drugs Fund Pazopanib Votrient®
09.01.06 Non Formulary Cancer Drugs Fund Pegfilgrastim Neulasta®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa Pegasys®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Alfa ViraferonPeg®
08.02.04 Formulary Cancer Drugs Fund Peginterferon Beta-1a Plegridy®
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta®
08.02.04 Formulary Cancer Drugs Fund Pemrolizumab Keytruda®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
03.11 Formulary Cancer Drugs Fund pirfenidone Esbriet®
08.01.02 Formulary Cancer Drugs Fund Pixantrone 
09.01.07 Non Formulary Cancer Drugs Fund Plerixafor Mozobil®
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig®
03.05.02 Formulary Cancer Drugs Fund Poractant Alfa Curosurf®
08.03.04.02 Formulary Cancer Drugs Fund Radium-223 dichloride 
05.03.01 Formulary Cancer Drugs Fund Raltegravir Isentress ®
08.01.03 Formulary Cancer Drugs Fund Raltitrexed Tomudex®
11.08.02 Formulary Cancer Drugs Fund Ranibizumab Lucentis®
10.01.04 Formulary Cancer Drugs Fund Rasburicase Fastertec
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga®
05.03.05 Formulary Cancer Drugs Fund Ribavirin 
08.01.05 Formulary Cancer Drugs Fund Ribociclib 
05.03.01 Formulary Cancer Drugs Fund Rilpivirine hydrochloride Edurant®
04.09.03 Formulary Cancer Drugs Fund Riluzole Rilutek®
05.03.01 Formulary Cancer Drugs Fund Ritonavir Norvir®
08.02.03 Formulary Cancer Drugs Fund Rituximab MabThera®Truxima ®
10.01.03 Formulary Cancer Drugs Fund Rituximab (rheumatology) MabThera®
09.01.04 Non Formulary Cancer Drugs Fund Romiplostim Nplate®
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib Jakavi®
09.04.01 Non Formulary Cancer Drugs Fund Sapropterin Dihydrochloride  Kuvan®
05.03.01 Formulary Cancer Drugs Fund Saquinavir Invirase®
10.01.03 Formulary Cancer Drugs Fund Sarilumab   (Kevzara®)
10.01.03 Formulary Cancer Drugs Fund Secukinumab 
13.05.03 Formulary Cancer Drugs Fund Secukinumab 
09.05.02.02 Non Formulary Cancer Drugs Fund Sevelamer Carbonate Renvela®
09.05.02.02 Non Formulary Cancer Drugs Fund Sevelamer Hydrochloride  Renagel®
20 Non Formulary Cancer Drugs Fund Sipuleucel- T 
08.02.02 Formulary Cancer Drugs Fund Sirolimus Rapamune®
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir Sovaldi®
05.03.03.02 Formulary Cancer Drugs Fund Sofosbuvir, Velpatasvir and Voxilaprevir Vosevi®
06.05.01 Formulary Cancer Drugs Fund Somatropin Omnitrope® Humatrope® genotropin® and Zomacton®
08.01.05 Formulary Cancer Drugs Fund Sorafenib Nexavar®
05.03.01 Formulary Cancer Drugs Fund Stavudine Zerit®
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent®
08.02.04 Formulary Cancer Drugs Fund Talimogene laherparepvac Imlygic®
08.01.05 Formulary Cancer Drugs Fund Talimogene laherparepvec Imlygic®
20 Non Formulary Cancer Drugs Fund Taribavirin 
05.03.03.02 Formulary Cancer Drugs Fund Telaprevir Incivo®
08.01.05 Formulary Cancer Drugs Fund Temozolomide Temodal®
08.01.05 Formulary Cancer Drugs Fund Temsirolimus Torisel®
05.03.01 Formulary Cancer Drugs Fund Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg Atripla®
05.03.01 Formulary Cancer Drugs Fund Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine Genvoya®
05.03.01 Formulary Cancer Drugs Fund Tenofovir and Emtricitabine Truvada®
05.03.01 Formulary Cancer Drugs Fund Tenofovir Disproxil Viread®
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild®
08.02.04 Formulary Cancer Drugs Fund Teriflunomide Aubagio®
20 Non Formulary Cancer Drugs Fund TETRAHYDROBIOPTERIN Tablets 10 mg 
08.02.04 Formulary Cancer Drugs Fund Thalidomide Celgene®
05.01.04 Formulary Cancer Drugs Fund Tobramycin 
05.01.04 Formulary Cancer Drugs Fund Tobramycin inhaler TOBI Podhaler®
10.01.03 Formulary Cancer Drugs Fund Tocilizumab RoActemra®
10.01.03 Formulary Cancer Drugs Fund Tofacitinib (Xeljanz®)
06.05.02 Formulary Cancer Drugs Fund Tolvaptan Jinarc®
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab Herceptin®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla®
20 Non Formulary Cancer Drugs Fund Treprostinil  
08.01.05 Formulary Cancer Drugs Fund Trifluridine and Tipiracil  Lonsurf ®
01.05.03 Formulary Cancer Drugs Fund Ustekinumab  Stelera ®
10.01.03 Formulary Cancer Drugs Fund Ustekinumab (Stelara)
13.05.03 Formulary Cancer Drugs Fund Ustekinumab 
05.03.02.02 Formulary Cancer Drugs Fund Valganciclovir Valcyte®
01.05.03 Formulary Cancer Drugs Fund Vedolizumab 
08.01.05 Formulary Cancer Drugs Fund Vemurafenib  (Zelboraf® )
08.01.05 Formulary Cancer Drugs Fund Vemurafenib Zelboraf®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto ®
11.08.02 Formulary Cancer Drugs Fund Verteporfin Visudyne®
05.02 Formulary Cancer Drugs Fund Voriconazole Vfend®
08.01.05 Restricted Use Cancer Drugs Fund Vosaroxin Qinprezo
05.03.01 Formulary Cancer Drugs Fund Zidovudine Retrovir®
Northern Lincolnshire